These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32833945)

  • 1. Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo.
    Coleman O; Henry M; O'Neill F; Roche S; Swan N; Geoghegan J; Conlon K; McVey G; Moriarty M; Meleady P; Clynes M
    Pancreas; 2020 Sep; 49(8):1109-1116. PubMed ID: 32833945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
    Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
    BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma.
    Shekouh AR; Thompson CC; Prime W; Campbell F; Hamlett J; Herrington CS; Lemoine NR; Crnogorac-Jurcevic T; Buechler MW; Friess H; Neoptolemos JP; Pennington SR; Costello E
    Proteomics; 2003 Oct; 3(10):1988-2001. PubMed ID: 14625861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells.
    Tian C; Clauser KR; Öhlund D; Rickelt S; Huang Y; Gupta M; Mani DR; Carr SA; Tuveson DA; Hynes RO
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19609-19618. PubMed ID: 31484774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative proteomic analysis for the detection of biomarkers in pancreatic ductal adenocarcinomas.
    Qi T; Han J; Cui Y; Zong M; Liu X; Zhu B
    J Clin Pathol; 2008 Jan; 61(1):49-58. PubMed ID: 17412869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling.
    Werner J; Bernhard P; Cosenza-Contreras M; Pinter N; Fahrner M; Pallavi P; Eberhard J; Bronsert P; Rückert F; Schilling O
    Neoplasia; 2023 Feb; 36():100871. PubMed ID: 36610378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice.
    Jandaghi P; Najafabadi HS; Bauer AS; Papadakis AI; Fassan M; Hall A; Monast A; von Knebel Doeberitz M; Neoptolemos JP; Costello E; Greenhalf W; Scarpa A; Sipos B; Auld D; Lathrop M; Park M; Büchler MW; Strobel O; Hackert T; Giese NA; Zogopoulos G; Sangwan V; Huang S; Riazalhosseini Y; Hoheisel JD
    Gastroenterology; 2016 Dec; 151(6):1218-1231. PubMed ID: 27578530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Analysis of Malignant Ascites From Patients With Pancreatic Ductal Adenocarcinoma.
    Kitamura F; Miyata T; Uemura N; Uchihara T; Imai K; Hayashi H; Yamashita YI; Matsusaki K; Ishimoto T; Baba H
    Anticancer Res; 2021 Jun; 41(6):2895-2900. PubMed ID: 34083280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the human pancreatic stellate cell secreted proteome.
    Wehr AY; Furth EE; Sangar V; Blair IA; Yu KH
    Pancreas; 2011 May; 40(4):557-66. PubMed ID: 21499210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead.
    Kim H; Park J; Wang JI; Kim Y
    Expert Rev Proteomics; 2017 Nov; 14(11):963-971. PubMed ID: 28926720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of pancreatic ductal adenocarcinoma cells reveals metabolic alterations.
    Zhou W; Capello M; Fredolini C; Piemonti L; Liotta LA; Novelli F; Petricoin EF
    J Proteome Res; 2011 Apr; 10(4):1944-52. PubMed ID: 21309613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival.
    Holm M; Saraswat M; Joenväärä S; Seppänen H; Renkonen R; Haglund C
    Tumour Biol; 2020 Jun; 42(6):1010428320936410. PubMed ID: 32586207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-complex level of cofilin-1 in sera is associated with cancer progression and poor prognosis in pancreatic cancer.
    Satoh M; Takano S; Sogawa K; Noda K; Yoshitomi H; Ishibashi M; Mogushi K; Takizawa H; Otsuka M; Shimizu H; Miyazaki M; Nomura F
    Cancer Sci; 2017 Apr; 108(4):795-803. PubMed ID: 28161904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
    Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
    Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relating pancreatic ductal adenocarcinoma tumor samples and cell lines using gene expression data in translational research.
    Shuaichen L; Guangyi W
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):157-162. PubMed ID: 29729710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer.
    Ger M; Kaupinis A; Petrulionis M; Kurlinkus B; Cicenas J; Sileikis A; Valius M; Strupas K
    Anticancer Res; 2018 Oct; 38(10):5759-5765. PubMed ID: 30275197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells.
    Zhou W; Capello M; Fredolini C; Racanicchi L; Piemonti L; Liotta LA; Novelli F; Petricoin EF
    J Proteome Res; 2012 Feb; 11(2):554-63. PubMed ID: 22050456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.